Similar Articles
1221 Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma
1222 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1223 Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
1224 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1225 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1226 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1227 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1228 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1229 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
1230 Role of innate immunity in the development of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA